Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the clinical equivalence and safety of the test
formulation of Lubiprostone 24 mcg capsules manufactured by Dr Reddy's Laboratories Ltd
compared to the marketed formulation AMITIZA® ( Lubiprostone) 24 mcg capsules (Sucampo
Pharmaceuticals, Inc.) in patients with confirmed Chronic Idiopathic Constipation